Erika Teresa Minetti

Ms. Erika Teresa Minetti

Boston University, Boston, Massachusetts, USA
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
YTYuko Tsukahara
Yuko Tsukahara
BFBeatriz Ferran
Beatriz Ferran
Erika Teresa MinettiErika Teresa Minetti
Erika Teresa Minetti
BCBrian S. H. Chong
Brian S. H. Chong
AGAdam C Gower
Adam C Gower
RMReiko Matsui
Reiko Matsui
Liver fibrosis is a sign of non-alcoholic fatty liver disease progression towards steatohepatitis (NASH) and cirrhosis and is accelerated by aging. Glutaredoxin-1 (Glrx) controls redox signaling by reversing protein S-glutathionylation, induced by oxidative stress, and its deletion causes fatty liver in mice. Although Glrx regulates various pathways, including metabolism and apoptosis, the impact of Glrx on liver fibrosis has not been studied. Therefore, we evaluated the role of Glrx in liver fibrosis induced by aging or by a high-fat, high-fructose diet. We found that: (1) upregulation of Glrx expression level inhibits age-induced hepatic apoptosis and liver fibrosis. In vitro studies indicate that Glrx regulates Fas-induced apoptosis in hepatocytes; (2) diet-induced NASH leads to reduced expression of Glrx and higher levels of S-glutathionylated proteins in the liver. In the NASH model, hepatocyte-specific adeno-associated virus-mediated Glrx overexpression (AAV-Hep-Glrx) suppresses fibrosis and apoptosis and improves liver function; (3) AAV-Hep-Glrx significantly inhibits transcription of Zbtb16 and negatively regulates immune pathways in the NASH liver. In conclusion, the upregulation of Glrx is a potential therapeutic for the reversal of NASH progression by attenuating inflammatory and fibrotic processes.

12 August 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
Erika Teresa MinettiErika Teresa Minetti
Erika Teresa Minetti
HEHanno Erythropel
Hanno Erythropel
RKRachel Keith
Rachel Keith
Danielle R DavisDanielle R Davis
Danielle R Davis
JZJulie B. Zimmerman
Julie B. Zimmerman
NHNaomi M. Hamburg
Naomi M. Hamburg
Background: After Massachusetts enacted regulation on flavored tobacco products in 2020, electronic cigarettes (e‐cigarettes) labeled “clear” emerged in the state. We studied their acute hemodynamic impact and chemical composition. Methods: In participants (age 18–45 years) in the Cardiovascular Injury due to Tobacco Products 2.0 study (Boston, MA), we measured changes in blood pressure and heart rate following a structured use of participants' own e‐cigarettes. We compared “clear” e‐cigarette users (N=23) with non‐“clear” flavored e‐cigarette users (N=111) and nonusers (N=73). We used gas chromatograph coupled with mass spectroscopy to characterize and quantify the presence of synthetic cooling agents (WS‐3, WS‐23), menthol, and nicotine, and other flavorants in 19 “clear” e‐cigarettes. Results: All “clear” e‐liquids contained the synthetic cooling agents WS‐23 and/or WS‐3, 18/19 contained menthol, and 12/19 products contained other flavorants. JUUL e‐liquids did not contain synthetic coolants. Baseline blood pressure and heart rate measures were similar between “clear” and non‐“clear” flavored e‐cigarette users. Following acute use, “clear” e‐cigarettes resulted in a greater increase in blood pressure and heart rate compared to both non‐“clear” flavored e‐cigarette use and nonuse, which remained largely consistent in multivariable models. For sensitivity analysis of comparing “clear” users to the subgroup of JUUL non‐“clear” flavored users, the directions of associations were similar. Conclusions: The presence of synthetic cooling agents along with traditional flavorants in “clear” e‐cigarette products available in the Massachusetts marketplace undermines the efficacy of the flavor ban. The potential that “clear” e‐cigarettes induced more pronounced hemodynamic effects necessitates further study of the health impact of these products and synthetic cooling agents. Registration: URL: https://www.medrxiv.org/content/10.1101/2024.04.18.24305863v1 , medRxiv. 10.1101/2024.04.18.24305863 .

19 April 2024 in medRxiv
Verified
Preprint
Open access
PDF file
Erika Teresa MinettiErika Teresa Minetti
Erika Teresa Minetti
HEHanno Erythropel
Hanno Erythropel
RKRachel J. Keith
Rachel J. Keith
Danielle R DavisDanielle R Davis
Danielle R Davis
JZJulie B. Zimmerman
Julie B. Zimmerman
NHNaomi M. Hamburg
Naomi M. Hamburg
Introduction Massachusetts (MA) enacted statewide regulation on all flavored tobacco products in June 2020. Thereafter, electronic cigarettes (e-cigarettes) labeled ‘clear’ emerged on the market. We aimed to combine cardiovascular health effects with chemical analysis of ‘clear’ e-cigarettes. Methods We measured acute changes in blood pressure and heart rate following a 10-minute structured use of participants’ own e-cigarette, comparing ‘clear’ e-cigarette users with other flavored e-cigarette users and non-users. Chemical characterization and quantification of relevant flavorings and cooling agents (WS-3, WS-23) of 19 ‘clear’-labeled disposable e-cigarette liquids was carried out by GC/MS. Results After the ban, participants that used ‘clear’ labeled e-cigarettes increased from 0% to 21%. Increase in diastolic blood pressure and heart rate was significantly greater in ‘clear’ e-cigarettes users (n=22) compared to both non-’clear’ flavored e-cigarette users (n=114) and non-users (n=72). We saw similar results in heart rate when comparing Juul e-cigarette and ‘clear’ users; Juul was used as a reference as synthetic coolants WS-3 or WS-23 were not detected in these. All (19/19) ‘clear’ e-liquids were found to contain synthetic cooling agents WS-23 and/or WS-3, menthol (18/19), as well as other flavorings (12/19). Discussion The detected presence of menthol alongside other flavorings in tested ‘clear’ products is a direct violation of the MA flavored tobacco product regulation, warranting stricter monitoring for new products and constituents. ‘clear’ e-cigarette use led to greater hemodynamic effects compared to other flavored e-cigarettes and Juul, which raises questions about the effect of cooling agents on users.